BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 24366573)

  • 21. Bone Marrow NK Cells: Origin, Distinctive Features, and Requirements for Tissue Localization.
    Bonanni V; Sciumè G; Santoni A; Bernardini G
    Front Immunol; 2019; 10():1569. PubMed ID: 31354722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional regulation of natural killer cell development and maturation.
    Kee BL; Morman RE; Sun M
    Adv Immunol; 2020; 146():1-28. PubMed ID: 32327150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity of NK Cells and Other Innate Lymphoid Cells in Human and Murine Decidua.
    Vacca P; Chiossone L; Mingari MC; Moretta L
    Front Immunol; 2019; 10():170. PubMed ID: 30800126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Innate lymphoid cells and the MHC.
    Robinette ML; Colonna M
    HLA; 2016 Jan; 87(1):5-11. PubMed ID: 26812060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. G-protein-coupled receptors in control of natural killer cell migration.
    Walzer T; Vivier E
    Trends Immunol; 2011 Oct; 32(10):486-92. PubMed ID: 21664184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural killer cell homing and trafficking in tissues and tumors: from biology to application.
    Ran GH; Lin YQ; Tian L; Zhang T; Yan DM; Yu JH; Deng YC
    Signal Transduct Target Ther; 2022 Jun; 7(1):205. PubMed ID: 35768424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow versus thymic pathways of natural killer cell development.
    Di Santo JP; Vosshenrich CA
    Immunol Rev; 2006 Dec; 214():35-46. PubMed ID: 17100874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemokines and NK cells: regulators of development, trafficking and functions.
    Bernardini G; Gismondi A; Santoni A
    Immunol Lett; 2012 Jul; 145(1-2):39-46. PubMed ID: 22698182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory NK-cell functions in inflammation and autoimmunity.
    Lünemann A; Lünemann JD; Münz C
    Mol Med; 2009; 15(9-10):352-8. PubMed ID: 19603102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NK cells in autoimmune disease.
    Johansson S; Hall H; Berg L; Höglund P
    Curr Top Microbiol Immunol; 2006; 298():259-77. PubMed ID: 16323418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CX3CR1 regulates the maintenance of KLRG1+ NK cells into the bone marrow by promoting their entry into circulation.
    Ponzetta A; Sciumè G; Benigni G; Antonangeli F; Morrone S; Santoni A; Bernardini G
    J Immunol; 2013 Dec; 191(11):5684-94. PubMed ID: 24184559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tuning the threshold of natural killer cell responses.
    Narni-Mancinelli E; Ugolini S; Vivier E
    Curr Opin Immunol; 2013 Feb; 25(1):53-8. PubMed ID: 23270590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular profiling reveals distinct functional attributes of CD1d-restricted natural killer (NK) T cell subsets.
    Rolf J; Berntman E; Stenström M; Smith EM; Månsson R; Stenstad H; Yamagata T; Agace W; Sigvardsson M; Cardell SL
    Mol Immunol; 2008 May; 45(9):2607-20. PubMed ID: 18304639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral blood NK cells from breast cancer patients are tumor-induced composite subsets.
    Mamessier E; Pradel LC; Thibult ML; Drevet C; Zouine A; Jacquemier J; Houvenaeghel G; Bertucci F; Birnbaum D; Olive D
    J Immunol; 2013 Mar; 190(5):2424-36. PubMed ID: 23359508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRTAM
    Ramírez-Ramírez D; Padilla-Castañeda S; Galán-Enríquez CS; Vadillo E; Prieto-Chávez JL; Jiménez-Hernández E; Vilchis-Ordóñez A; Sandoval A; Balandrán JC; Pérez-Tapia SM; Ortiz-Navarrete V; Pelayo R
    J Leukoc Biol; 2019 May; 105(5):999-1013. PubMed ID: 30791148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NK cells: elusive players in autoimmunity.
    Johansson S; Berg L; Hall H; Höglund P
    Trends Immunol; 2005 Nov; 26(11):613-8. PubMed ID: 16118064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple Myeloma Impairs Bone Marrow Localization of Effector Natural Killer Cells by Altering the Chemokine Microenvironment.
    Ponzetta A; Benigni G; Antonangeli F; Sciumè G; Sanseviero E; Zingoni A; Ricciardi MR; Petrucci MT; Santoni A; Bernardini G
    Cancer Res; 2015 Nov; 75(22):4766-77. PubMed ID: 26438594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency and phenotype of natural killer cells and natural killer cell subsets in bovine lymphoid compartments and blood.
    Hamilton CA; Mahan S; Bell CR; Villarreal-Ramos B; Charleston B; Entrican G; Hope JC
    Immunology; 2017 May; 151(1):89-97. PubMed ID: 28063176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of bone marrow NK cells during SIV infection is associated with increased turnover rates and cytotoxicity but not changes in trafficking.
    Li H; Evans TI; Reeves RK
    J Med Primatol; 2013 Oct; 42(5):230-6. PubMed ID: 23898936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Innate immunity and autoimmunity: from self-protection to self-destruction.
    Shi FD; Ljunggren HG; Sarvetnick N
    Trends Immunol; 2001 Feb; 22(2):97-101. PubMed ID: 11286711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.